Navigation Links
Lilly Statement Regarding President Obama's Meeting With U.S. Business Leaders

INDIANAPOLIS, Dec. 15, 2010 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today issued the following statement from John Lechleiter, Ph.D., chairman, president, and chief executive officer about his meeting today with President Obama and other business leaders regarding economic growth, job creation, American innovation and competiveness:

"It's an honor to represent Lilly and the biopharmaceutical industry and take part in this very important dialogue today with the President and other leaders across many industries. Fostering an environment that encourages innovation is fundamental to American job growth. For instance, our industry has a long history of addressing critical medical needs through innovative research and discovery. We need policies that support and help sustain American innovation.

"We also believe that local innovation hubs – such as the life science hub we have in Indiana -- can serve as the fuel for national prosperity. From 2001 to 2007, employment in Indiana life sciences industries grew at more than twice the national rate. The annual wage of a typical life sciences job in Indiana is more than double the average wage in the state. And the total value of Indiana life sciences exports more than doubled between 2002 and 2007. I look forward to discussing how Indiana's success story can be used as a model for job growth.

"Ultimately, with public policies that provide the right environment, I'm convinced America can out-innovate anyone and create a new wave of good jobs here at home."

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at C-LLY


SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Suspends Phase III Trial in Metastatic Melanoma
2. Lilly Declares First-Quarter 2011 Dividend
3. U.S. District Court Rules from Bench in Lillys Favor, Confirms Validity of Alimta Patent
4. Lilly Surpasses United Way 2010 Campaign Goal
5. Breast Cancer Message Barred in Eli Lillys Hometown
6. Eli Lilly and Company to Open a Diabetes-Focused Research Center in China
7. Lilly USA, LLC Wins Award in 2010 National Health Information Awards Program
8. Lilly CEO: Are We Getting Our Moneys Worth from Medical Innovation?
9. MacroGenics and Lilly Announce Pivotal Clinical Trial of Teplizumab Did Not Meet Primary Efficacy Endpoint
10. Eli Lilly and Company and PPD, Inc., Honored for Building Strong Clinical Research Site Partnerships at the Site Solutions Summit Annual Meeting
11. Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™
Post Your Comments:
(Date:12/1/2015)... DUBLIN , Dec. 01, 2015 /PRNewswire/ ... announced the addition of the "Medium ... Adhesives, Sealants, Lubricants, and Other Applications - ... and Forecast, 2015 - 2023" report ... ) has announced the addition of the ...
(Date:12/1/2015)... , Dec. 01, 2015 ... the addition of the "Spinal Muscular ... Trends, and Forecast 2015 - 2023" ... ) has announced the addition of ... Pipeline Assessment, Size, Growth, Trends, and Forecast ...
(Date:12/1/2015)... 1, 2015   Nottingham Spirk , a ... the publication of a free whitepaper , ... Market". The whitepaper gives medical product companies, pharmaceutical ... this lucrative segment. Nottingham Spirk ... manage their own health, save money (i.e., fewer ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... ... ClinicoEconomics and Outcomes Research has published the ... ”. , As corresponding author Dr Ankita Modi says “Pre-existing gastrointestinal events may ... a large US managed care database, women aged 55 years or older with ...
(Date:12/1/2015)... ... ... Hospital Tampa is the first health care provider in the region to offer the ... is a vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult ... least 40 to 45 kg, or a BMI of at least 35 to 39.9 kg ...
(Date:12/1/2015)... Fla. (PRWEB) , ... December 01, 2015 , ... ... number of leadless pacemakers in the U.S. and is the only hospital in ... from the largest clinical data presentation of transcatheter pacing patients were revealed recently ...
(Date:12/1/2015)... ... December 01, 2015 , ... Speech and physical therapies ... with innovative technologies and under the right circumstances, these practices can be merged. ... a dual-approach to his or her therapeutic sessions, as well as gives the ...
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, 2015—Since the ... in scientific research and discoveries, leading us to better understand the disease’s behavior. ... those affected by HIV/AIDS. Mediaplanet’s cross-platform edition of “World AIDS Day” provides insight ...
Breaking Medicine News(10 mins):